Detalhe da pesquisa
1.
ALKBH5 regulates paclitaxel resistance in NSCLC via inhibiting CEMIP-mediated EMT.
Toxicol Appl Pharmacol
; 483: 116807, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38199493
2.
Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function.
Drug Resist Updat
; 57: 100770, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175687
3.
Kukoamine A Protects against NMDA-Induced Neurotoxicity Accompanied with Down-Regulation of GluN2B-Containing NMDA Receptors and Phosphorylation of PI3K/Akt/GSK-3ß Signaling Pathway in Cultured Primary Cortical Neurons.
Neurochem Res
; 45(11): 2703-2711, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32892226
4.
Neuroprotection by Kukoamine A against oxidative stress may involve N-methyl-D-aspartate receptors.
Biochim Biophys Acta
; 1850(2): 287-98, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25445711
5.
Understanding and Targeting the Epigenetic Regulation to Overcome EGFR-TKIs Resistance in Human Cancer.
Recent Pat Anticancer Drug Discov
; 18(4): 506-516, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464873
6.
Kukoamine A Prevents Radiation-Induced Neuroinflammation and Preserves Hippocampal Neurogenesis in Rats by Inhibiting Activation of NF-κB and AP-1.
Neurotox Res
; 31(2): 259-268, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27815817
7.
Pretreatment of MQA, a caffeoylquinic acid derivative compound, protects against H2O2-induced oxidative stress in SH-SY5Y cells.
Neurol Res
; 38(12): 1079-1087, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27800716
8.
Compound MQA, a Caffeoylquinic Acid Derivative, Protects Against NMDA-Induced Neurotoxicity and Potential Mechanisms In Vitro.
CNS Neurosci Ther
; 21(7): 575-84, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26096046
9.
Neuroprotective effects of Kukoamine B against hydrogen peroxide-induced apoptosis and potential mechanisms in SH-SY5Y cells.
Environ Toxicol Pharmacol
; 40(1): 230-40, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26164594